Nuveen
RVMD icon

Nuveen’s Revolution Medicines RVMD Stock Holding History

Nuveen’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89M Buy
475,231
+134,620
+40% +$19.7M 0.02% 466
2026
Q1 		$33.1M Sell
340,611
-65,630
-16% -$6.63M 0.01% 851
2025
Q4 		$32.4M Buy
406,241
+68,767
+20% +$4.51M 0.01% 859
2025
Q3 		$15.8M Buy
337,474
+79,972
+31% +$3.13M ﹤0.01% 1282
2025
Q2 		$9.47M Sell
257,502
-220,358
-46% -$8.47M ﹤0.01% 1549
2025
Q1 		$16.9M Buy
477,860
+4,132
+0.9% +$168K 0.01% 1230
2024
Q4 		$20.7M Buy
473,728
+14,391
+3% +$726K 0.01% 1177
2024
Q3 		$20.8M Buy
459,337
+4,205
+0.9% +$183K 0.01% 1167
2024
Q2 		$17.7M Buy
455,132
+81,357
+22% +$3.04M 0.01% 1214
2024
Q1 		$12M Sell
373,775
-10,893
-3% -$323K ﹤0.01% 1488
2023
Q4 		$11M Buy
384,668
+109,723
+40% +$2.64M ﹤0.01% 1529
2023
Q3 		$7.61M Sell
274,945
-2,445
-0.9% -$72.5K ﹤0.01% 1632
2023
Q2 		$7.42M Buy
277,390
+38,569
+16% +$946K ﹤0.01% 1682
2023
Q1 		$5.17M Buy
238,821
+37,669
+19% +$928K ﹤0.01% 1868
2022
Q4 		$4.79M Sell
201,152
-30,952
-13% -$658K ﹤0.01% 1928
2022
Q3 		$4.58M Buy
232,104
+20,612
+10% +$453K ﹤0.01% 1956
2022
Q2 		$4.12M Buy
211,492
+2,524
+1% +$49.1K ﹤0.01% 2071
2022
Q1 		$4.34M Sell
208,968
-7,149
-3% -$156K ﹤0.01% 2137
2021
Q4 		$5.44M Sell
216,117
-126,158
-37% -$3.56M ﹤0.01% 2068
2021
Q3 		$9.42M Sell
342,275
-27,705
-7% -$806K ﹤0.01% 1824
2021
Q2 		$11.7M Buy
369,980
+162,602
+78% +$5.68M ﹤0.01% 1761
2021
Q1 		$9.52M Buy
207,378
+54,518
+36% +$2.44M ﹤0.01% 1829
2020
Q4 		$6.05M Buy
152,860
+713
+0.5% +$28.2K ﹤0.01% 1971
2020
Q3 		$5.29M Buy
152,147
+23,210
+18% +$643K ﹤0.01% 1885
2020
Q2 		$4.07M Buy
128,937
+48,352
+60% +$1.52M ﹤0.01% 2013
2020
Q1 		$1.77M Buy
+80,585
New +$2.23M ﹤0.01% 2248

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Nuveen's RVMD Position: Q2 2026 in Review

Nuveen increased its Revolution Medicines (RVMD) stake by 40% in Q2 2026, buying an estimated $19.7M and bringing the position to 475,231 shares worth $89M. The position accounts for 0.02% of the portfolio, ranked #466.

Nuveen first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Nuveen held 475,231 shares of Revolution Medicines worth $89M as of Q2 2026.
  • Nuveen bought 134,620 Revolution Medicines shares in Q2 2026, an estimated $19.7M.
  • Revolution Medicines made up 0.02% of Nuveen's portfolio in Q2 2026, its #466 holding.
  • Nuveen first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.